Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Focal facial dermal dysplasia type II (FFDD2) is a focal facial dermal dysplasia (FFDD), characterized by congenital bitemporal scar-like depressions and other facial and organ abnormalities.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for focal facial dermal dysplasia type II.
3 publications have been identified in PubMed for focal facial dermal dysplasia type II. Research spans Review / Meta-Analysis (67%) and Case Report / Case Series (33%).
Prasanna S (2026). [PMID: 41717942](https://pubmed.ncbi.nlm.nih.gov/41717942/). *Indian Dermatol Online J*. [Review / Meta-Analysis]
Di Marco G (2025). [PMID: 40265342](https://pubmed.ncbi.nlm.nih.gov/40265342/). *Dermatopathology (Basel)*. [Review / Meta-Analysis]
Gnesotto L (2025). [PMID: 40231353](https://pubmed.ncbi.nlm.nih.gov/40231353/). *Dermatol Reports*. [Case Report / Case Series]
Data assembled from 4 of 12 sources · Last updated Sep 18, 2026, 9:44 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center